Cloud computing provides resources over the Internet and allows a plethora of applications to be deployed to provide services for different industries. The major bottleneck being faced currently in these cloud frameworks is their limited scalability and hence inability to cater to the requirements of centralized Internet of Things (IoT) based compute environments. The main reason for this is that latency-sensitive applications like health monitoring and surveillance systems now require computation over large amounts of data (Big Data) transferred to centralized database and from database to cloud data centers which leads to drop in performance of such systems. The new paradigms of fog and edge computing provide innovative solutions by bringing resources closer to the user and provide low latency and energy efficient solutions for data processing compared to cloud domains. Still, the current fog models have many limitations and focus from a limited perspective on either accuracy of results or reduced response time but not both. We proposed a novel framework called HealthFog for integrating ensemble deep learning in Edge computing devices and deployed it for a real-life application of automatic Heart Disease analysis. HealthFog delivers healthcare as a fog service using IoT devices and efficiently manages the data of heart patients, which comes as user requests. Fog-enabled cloud framework, FogBus is used to deploy and test the performance of the proposed model in terms of power consumption, network bandwidth, latency, jitter, accuracy and execution time. HealthFog is configurable to various operation modes which provide the best Quality of Service or prediction accuracy, as required, in diverse fog computation scenarios and for different user requirements.
Blood transfusion refers to the perioperative administration of blood and blood components. Adherence to proper indications for blood component therapy is essential because of its potential adverse effects and costs of transfusion. Over the years, the significance of blood components in treating certain diseases or conditions has been recognized. In this article, the most commonly used blood components along with the new developments in component therapy have been discussed. Recommendations by different academic and clinical trials and studies have been presented for quick reference. The individual coagulation factors are discussed in brief.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.